Search
Now showing items 1-10 of 23
Coronavirus conspiracy beliefs, mistrust, and compliance with government guidelines in England
(2020-05)
Background: An invisible threat has visibly altered the world. Governments and key institutions have had to implement decisive responses to the danger posed by the coronavirus pandemic. Imposed change will increase the ...
Catastrophic cognitions about coronavirus: the Oxford psychological investigation of coronavirus questionnaire [TOPIC-Q]
(2021-01)
Background: Cognitive therapies are developed on the principle that specific cognitive appraisals are key determinants in the development and maintenance of mental health disorders. It is likely that particular appraisals ...
Newly qualified health visitor: COVID-19 – a public health crisis
(2020-04)
Bethany Boddy explores the fast-changing public health emergency of COVID-19 and the health visitor response.
Could health-improving interventions address the growing unemployment crisis?
(2021-02)
The COVID-19 pandemic is causing unprecedented rates of unemployment. Poorer mental health is a cause and a consequence of unemployment, and job seekers with poorer mental health remain unemployed for longer. The review ...
Promoting safety in the home during the pandemic and beyond
(2021-03)
With families home schooling their children, caring for young babies and managing housework during lockdown, it is important for health visitors to promote home safety advice to help prevent unintentional accidents and injuries
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
(2021-04)
Background
A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 ...
Public opinion on global rollout of COVID-19 vaccines
(2021-03)
To the Editor—Vaccination programs for COVID-19 in ‘high-income countries’ (HICs) have benefited from their ability to secure contracts for preferential supply for several vaccines1. For the rest of the world, vaccine ...
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
(2021-06)
Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein ...
Why is COVID-19 associated with mental illness?
(2021-08)
The COVID-19 pandemic has taken a toll on people’s mental health.
Besides the indirect impact of the pandemic, a diagnosis of COVID 19 is itself associated with a greater risk of subsequent mental
illness. Conversely, ...
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
(2021-09)
COVID-19 vaccine supply shortages are causing concerns about compromised immunity in some countries as the interval between the first and second dose becomes longer. Conversely, countries with no supply constraints are ...